Llewellyn Spargo

543 total citations
22 papers, 406 citations indexed

About

Llewellyn Spargo is a scholar working on Rheumatology, Immunology and Genetics. According to data from OpenAlex, Llewellyn Spargo has authored 22 papers receiving a total of 406 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Rheumatology, 6 papers in Immunology and 5 papers in Genetics. Recurrent topics in Llewellyn Spargo's work include Rheumatoid Arthritis Research and Therapies (12 papers), Chronic Lymphocytic Leukemia Research (5 papers) and Systemic Lupus Erythematosus Research (5 papers). Llewellyn Spargo is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (12 papers), Chronic Lymphocytic Leukemia Research (5 papers) and Systemic Lupus Erythematosus Research (5 papers). Llewellyn Spargo collaborates with scholars based in Australia, United Kingdom and Malaysia. Llewellyn Spargo's co-authors include Leslie G. Cleland, Susanna Proudman, Graham Mayrhofer, Robert G. Metcalf, Michael J. James, Mihir D. Wechalekar, Thomas Sullivan, Michael D. Wiese, Maureen Rischmueller and Neville Gully and has published in prestigious journals such as The Journal of Immunology, Annals of the Rheumatic Diseases and British Journal Of Nutrition.

In The Last Decade

Llewellyn Spargo

21 papers receiving 399 citations

Peers

Countries citing papers authored by Llewellyn Spargo

Since Specialization

Citations

This map shows the geographic impact of Llewellyn Spargo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Llewellyn Spargo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Llewellyn Spargo more than expected).

Fields of papers citing papers by Llewellyn Spargo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Llewellyn Spargo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Llewellyn Spargo. The network helps show where Llewellyn Spargo may publish in the future.

Co-authorship network of co-authors of Llewellyn Spargo

This figure shows the co-authorship network connecting the top 25 collaborators of Llewellyn Spargo. A scholar is included among the top collaborators of Llewellyn Spargo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Llewellyn Spargo. Llewellyn Spargo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Modifiable Lifestyle Factors Associated With Response to Treatment in Early Rheumatoid Arthritis 2020 ·ACR Open Rheumatology ·Zoe Brown, Robert G. Metcalf, Jana Bednarz, Llewellyn Spargo, Anita Lee, Catherine Hill, Mihir D. Wechalekar, (unknown), Michael J. James, Les Cleland, Susanna Proudman	8
2	Scleroderma in Cairns: an epidemiological study 2019 ·Internal Medicine Journal ·(unknown), (unknown), Llewellyn Spargo, Caroline de Costa, (unknown), Susanna Proudman, David Bossingham	10
3	Effect of Adherence to Protocolized Targeted Intensifications of Disease-modifying Antirheumatic Drugs on Treatment Outcomes in Rheumatoid Arthritis: Results from an Australian Early Arthritis Cohort 2016 ·The Journal of Rheumatology ·Nasir Wabe, Michael J. Sorich, Mihir D. Wechalekar, Leslie G. Cleland, (unknown), (unknown), Llewellyn Spargo, Robert G. Metcalf, Cindy Hall, Susanna Proudman, Michael D. Wiese	11
4	Drug-induced toxicity and patient reported outcomes in rheumatoid arthritis patients following intensive treated-to-target strategy: does ceasing therapy due to toxicity worsen outcomes in long term? 2016 ·International Journal of Clinical Practice ·Nasir Wabe, Michael J. Sorich, Mihir D. Wechalekar, Leslie G. Cleland, (unknown), (unknown), Cindy Hall, Llewellyn Spargo, Robert G. Metcalf, Susanna Proudman, Michael D. Wiese	2
5	THU0070 RANKL, OPG and OSCAR but Not Dkk-1 Predict Radiographic Progression in An Inception Cohort of Seropositive Rheumatoid Arthritis (RA) Treated-To-Target with Combination Conventional DMARD Therapy 2016 ·Annals of the Rheumatic Diseases ·Mihir D. Wechalekar, Susan Lester, Sunil Nagpal, Suzanne Cole, Anuk Das, Pravin Hissaria, Tania N. Crotti, Llewellyn Spargo, Jenny Walker, Mark D. Smith, Susanna Proudman	3
6	Plasma n-3 fatty acids and clinical outcomes in recent-onset rheumatoid arthritis 2015 ·British Journal Of Nutrition ·Susanna Proudman, Leslie G. Cleland, Robert G. Metcalf, Thomas Sullivan, Llewellyn Spargo, Michael J. James	28
7	Characterising deviation from treat-to-target strategies for early rheumatoid arthritis: the first three years 2015 ·Arthritis Research & Therapy ·Nasir Wabe, Michael J. Sorich, Mihir D. Wechalekar, Leslie G. Cleland, (unknown), Anita Lee, Llewellyn Spargo, Robert G. Metcalf, Cindy Hall, Susanna Proudman, Michael D. Wiese	18
8	Determining the acceptable level of physician compliance with a treat‐to‐target strategy in early rheumatoid arthritis 2015 ·International Journal of Rheumatic Diseases ·Nasir Wabe, Michael J. Sorich, Mihir D. Wechalekar, Leslie G. Cleland, (unknown), Anita Lee, Llewellyn Spargo, Robert G. Metcalf, Cindy Hall, Susanna Proudman, Michael D. Wiese	8
9	Fish oil in recent onset rheumatoid arthritis: A randomized, double-blind, controlled trial within algorithm-based drug use 2014 ·PharmaNutrition ·Susanna Proudman, Leslie G. Cleland, Llewellyn Spargo, Cindy Hall, (unknown), (unknown), Robert A. Gibson, Michael J. James	0
10	The rheumatoid arthritis susceptibility polymorphismPTPN22C1858T is not associated with leflunomide response or toxicity 2014 ·Journal of Clinical Pharmacy and Therapeutics ·Ashley M. Hopkins, (unknown), David Foster, Vijayaprakash Suppiah, Richard N. Upton, Llewellyn Spargo, Leslie G. Cleland, Susanna Proudman, Michael D. Wiese	7
11	Porphyromonas gingivalis peptidylarginine deiminase substrate specificity 2013 ·Anaerobe ·(unknown), (unknown), Llewellyn Spargo, Richard M. Logan, Neville Gully	44
12	Fish oil in recent onset rheumatoid arthritis: a randomised, double-blind controlled trial within algorithm-based drug use 2013 ·Annals of the Rheumatic Diseases ·Susanna Proudman, Michael J. James, Llewellyn Spargo, Robert G. Metcalf, Thomas Sullivan, Maureen Rischmueller, (unknown), Mihir D. Wechalekar, (unknown), Leslie G. Cleland	113
13	Decline in Hand Bone Mineral Density Indicates Increased Risk of Erosive Change in Early Rheumatoid Arthritis 2013 ·Arthritis Care & Research ·Rachel Black, Llewellyn Spargo, Christopher G. Schultz, B. E. Chatterton, Leslie G. Cleland, Sue Lester, Catherine Hill, Susanna Proudman	13
14	Polymorphisms in cytochrome P450 2C19 enzyme and cessation of leflunomide in patients with rheumatoid arthritis 2012 ·Arthritis Research & Therapy ·Michael D. Wiese, (unknown), Catherine O’Doherty, Llewellyn Spargo, Michael J. Sorich, Leslie G. Cleland, Susanna Proudman	32
15	Recruitment and proliferation of CD4+ T cells in synovium following adoptive transfer of adjuvant-induced arthritis 2006 ·International Immunology ·Llewellyn Spargo, Leslie G. Cleland, (unknown), Graham Mayrhofer	8
16	Blockade of IFN‐γ does not affect the arthritogenicity of T cells generated during the induction of adjuvant arthritis but exacerbates the polyarthritis produced by adoptive transfer of arthritogenic effector cells 2005 ·Immunology and Cell Biology ·(unknown), Llewellyn Spargo, Graham Mayrhofer, Leslie G. Cleland	5
17	Temporal changes in the distribution of thoracic duct lymphoblasts to synovium and other tissues of rats with adjuvant‐induced arthritis 2002 ·Immunology and Cell Biology ·Leslie G. Cleland, (unknown), Llewellyn Spargo, Graham Mayrhofer	3
18	Characterization of thoracic duct cells that transfer polyarthritis 2001 ·Clinical & Experimental Immunology ·Llewellyn Spargo, Les Cleland, (unknown), Joanna S. Hawkes, Graham Mayrhofer	12
19	Recruitment of lymphoblasts derived from peripheral and intestinal lymph to synovium and other tissues in normal rats and rats with adjuvant arthritis 1996 ·The Journal of Immunology ·Llewellyn Spargo, Joanna S. Hawkes, Les Cleland, Graham Mayrhofer	19
20	Distribution of class II major histocompatibility antigens in enterocytes of the rat jejunum and their association with organelles of the endocytic pathway. 1990 ·PubMed ·Graham Mayrhofer, Llewellyn Spargo	28

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact